BIOMARIN PHARMACEUTICAL INC's ticker is and the CUSIP is 09061GAF8. A total of 40 filers reported holding BIOMARIN PHARMACEUTICAL INC in Q1 2018. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2018 | $3,442,000 | -72.8% | 2,857,000 | -73.2% | 0.42% | -72.7% |
| Q2 2018 | $12,667,000 | +0.2% | 10,648,000 | -6.8% | 1.53% | +13.2% |
| Q1 2018 | $12,642,000 | -5.0% | 11,428,000 | +2.2% | 1.35% | -10.8% |
| Q4 2017 | $13,303,000 | +65.1% | 11,185,000 | +66.8% | 1.52% | +81.1% |
| Q3 2017 | $8,057,000 | -72.4% | 6,704,000 | -72.6% | 0.84% | -68.2% |
| Q2 2017 | $29,225,000 | +4.6% | 24,469,000 | +3.8% | 2.63% | +9.7% |
| Q1 2017 | $27,939,000 | -8.7% | 23,565,000 | -9.4% | 2.40% | +1.4% |
| Q4 2016 | $30,609,000 | +72.3% | 26,009,000 | +83.3% | 2.37% | +72.7% |
| Q3 2016 | $17,768,000 | +22.9% | 14,193,000 | +14.0% | 1.37% | +10.8% |
| Q2 2016 | $14,458,000 | – | 12,450,000 | – | 1.24% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SCHRODER INVESTMENT MANAGEMENT GROUP | 12,400,000 | $1,340,750,000,000 | 1.66% |
| OAKTREE CAPITAL MANAGEMENT LP | 66,800,000 | $70,446,000 | 1.23% |
| Man Investments (CH) AG | 2,600,000 | $2,743,000 | 1.11% |
| GUARDIAN LIFE INSURANCE CO OF AMERICA | 8,000,000 | $8,425,000 | 0.81% |
| ADVENT CAPITAL MANAGEMENT /DE/ | 35,763,000 | $38,870,000 | 0.58% |
| Jabre Capital Partners S.A. | 5,900,000 | $6,240,000 | 0.44% |
| SSI INVESTMENT MANAGEMENT LLC | 3,039,000 | $3,198,000 | 0.31% |
| AVIVA PLC | 37,700,000 | $39,724,000 | 0.30% |
| BNP PARIBAS FINANCIAL MARKETS | 3,000,000 | $315,929,984,000 | 0.30% |
| Calamos Advisors LLC | 44,222,000 | $46,596,000 | 0.30% |